Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.33 USD | +6.52% | +4.91% | -15.52% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.52% | 1.98B | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.90% | 22.25B | |
-14.77% | 21.68B | |
-8.86% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing